BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival

Head and Neck

Volumn 33, Issue 5, 2011, Pages 727-733

  Rizzardi, Clara ^a   Torelli, Lucio ^a   Barresi, Elena ^a   Schneider, Manuela ^b   Canzonieri, Vincenzo ^c   Biasotto, Matteo ^a   Di Lenarda, Roberto ^a   Melato, Mauro ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Azienda per i Servizi Sanitari N 2 Isontina   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

BUBR1; oral; prognostic factor; spindle checkpoint; squamous cell carcinoma

Indexed keywords

BUB1 RELATED PROTEIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; ORAL SQUAMOUS CELL CARCINOMA; PHYSICAL PARAMETERS; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; SOFT TISSUE METASTASIS; SQUAMOUS CELL CARCINOMA;

EID: 79954479155     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21532     Document Type: Article

References (40)

1. Bharadwaj R, Yu H,. The spindle checkpoint, aneuploidy, and cancer. Oncogene 2004; 23: 2016-2027. (Pubitemid 38496731)
2. Jallepalli PV, Lengauer C,. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001; 1: 109-117. (Pubitemid 33741886)
3. Rajagopalan H, Lengauer C,. Aneuploidy and cancer. Nature 2004; 432: 338-341. (Pubitemid 39551662)
4. Kops GJ, Weaver BA, Cleveland DW,. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-785. (Pubitemid 41400777)
5. Lampson MA, Kapoor TM,. The human mitotic checkpoint protein BUBR1 regulates chromosome-spindle attachments. Nat Cell Biol 2005; 7: 93-98. (Pubitemid 40123388)
6. Wassmann K, Benezra R,. Mitotic checkpoints: from yeast to cancer. Curr Opin Genet Dev 1999; 11: 83-90. (Pubitemid 32119283)
7. Haruki N, Saito H, Harano T, et al. Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett 2001; 162: 201-205. (Pubitemid 32056289)
8. Sato M, Sekido Y, Horio Y, et al. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn J Cancer Res 2000; 91: 504-509. (Pubitemid 30392321)
9. Olesen SH, Thykjaer T, Ãrntoft TF,. Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis 2001; 22: 813-815. (Pubitemid 32447930)
10. Reis RM, Nakamura M, Masuoka J, et al. Mutation analysis of hBUBR1 and hBUBR3 genes in glioblastomas. Acta Neuropathol 2001; 101: 297-304. (Pubitemid 32372418)
11. Ouyang B, Knauf JA, Ain K, Nacev B, Fagin JA,. Mechanisms of aneuploidy in thyroid cancer cells lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin Endocrinol (Oxf) 2002; 56: 341-350. (Pubitemid 34310012)
12. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y,. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res 2002; 62: 13-17. (Pubitemid 34073977)
13. Saeki A, Tamura S, Ito N, et al. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer 2002; 94: 2047-2054. (Pubitemid 34270059)
14. Myrie KA, Percy MJ, Azim JN, Neeley CK, Petty EM,. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett 2000; 152: 193-199. (Pubitemid 30201502)
15. Yuan B, Xu Y, Woo JH, et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 2006; 12: 405-410. (Pubitemid 43166128)
16. Seike M, Gemma A, Hosoya Y, et al. The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer 2002; 38: 229-234. (Pubitemid 35341797)
17. Burum-Auensen E, De Angelis PM, SchjÃlberg AR, RÃislien J, MjÃ¥land O, Clausen OP,. Reduced level of the spindle checkpoint protein BUB1B associated with aneuploidy in colorectal cancers. Cell Prolif 2008; 41: 645-659.
18. Ando K, Kakeji Y, Kitao H, et al. High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci 2010; 101: 639-645.
19. Grabsch H, Takeno S, Parsons WJ, et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer: association with tumor cell proliferation. J Pathol 2003; 200: 16-22. (Pubitemid 36592631)
20. Scintu M, Vitale R, Prencipe M, et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett 2007; 254: 298-307. (Pubitemid 47126694)
21. Yamamoto Y, Matsuyama H, Chochi Y, et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet 2007; 174: 42-47. (Pubitemid 46365984)
22. Pinto M, Vieira J, Ribeiro FR, et al. Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol 2008; 30: 389-395.
23. Tanaka K, Mohri Y, Ohi M, et al. Mitotic checkpoint genes, hsMAD2 and BUBR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clin Oncol 2008; 20: 639-646.
24. Wada N, Yoshida A, Miyagi Y, et al. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Anticancer Res 2008; 28: 139-144. (Pubitemid 351362893)
25. Lee YK, Choi E, Kim MA, Park PG, Park NH, Lee H,. BUBR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. Br J Cancer 2009; 101: 504-510.
26. Ko YH, Roh JH, Son YI, et al. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. J Oral Pathol Med 2009; 39: 349-355.
27. Liu AW, Cai J, Zhao XL, et al. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma. J Clin Pathol 2009; 62: 1003-1008.
28. Shin HJ, Baek KH, Jeon AH, et al. Dual roles of human BUBR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 2003; 4: 483-497.
29. Minhas KM, Singh B, Jiang WW, Sidransky D, Califano JA,. Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int J Cancer 2003; 107: 46-52. (Pubitemid 37100084)
30. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S,. Overexpression of Cdc20 leads to impairment of spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 2007; 28: 81-92. (Pubitemid 44942629)
31. Thirthagiri E, Robinson CM, Huntley S, et al. Spindle assembly checkpoint and centrosome abnormalities in oral cancer. Cancer Lett 2007; 258: 276-285. (Pubitemid 350101025)
32. Nakagawa H, Yokozaki H, Oue N, et al. No mutations of the Bub1 gene in human gastric and oral cancer cell lines. Oncol Rep 2002; 9: 1229-1232.
33. Qi G, Ogawa I, Kudo Y, et al. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch 2007; 450: 297-302. (Pubitemid 46376560)
34. Hannisdal K, Burum-Auensen E, SchjÃlberg A, De Angelis PM, Clausen OP,. Correlation between reduced expression of the spindle checkpoint protein BubR1 and bad prognosis in tonsillar carcinomas. Head Neck 2010;Feb 9 [Epub ahead of print].
35. Lira RC, Miranda FA, Guimarães MC, et al. BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. Oncol Rep 2010; 23: 1027-1036.
36. Burum-Auensen E, De Angelis PM, SchjÃlberg AR, Kravik KL, Aure M, Clausen OP,. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry. J Histochem Cytochem 2007; 55: 477-486. (Pubitemid 46668629)
37. Hsieh PC, Chen YK, Tsai KB, et al. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 257-267.
38. Cheung HW, Jin DY, Ling MT, et al. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res 2005; 65: 1450-1458.
39. Sudo T, Nitta M, Saya H, Ueno NT,. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 2004; 64: 2502-2508. (Pubitemid 38523906)
40. Wang X, Jin DJ, Ng RW, et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 2002; 62: 1662-1668. (Pubitemid 34408486)